European Study of Cardiovascular Risk

Completed

• Conditions: Cardiovascular Risk Factors; Hyperlipidemia; Hypertension; Diabetes; Obesity; Smoking

• Registration Number: NCT00882336
• Lead Sponsor: AstraZeneca

Brief Summary

The main objective of this study is to describe the management of patients with cardiovascular risk factors in primary prevention among different European countries.

The patient's participation consists of a single study visit during a routine visit of the patient to the clinic/office.

Study variables will be measured:

* By an interview between physician and patient during the visit and/or available medical records' information: social and demographic patient characteristics, relevant family medical history, current medication.

* By questions asked to the physician: physician perception of patients' CV risk factor, guidelines adherence and cost-containment.

* By measurement performed to the patient during the visit: weight, height, BMI, waist and hip circumference will be measured.

* CV risk factors (blood parameters) will be measured by collecting available data documented within the last year in the medical records and by the collection and analyses of a blood sample during the visit.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2009-04-15
• Study First Submitted QC: 2009-04-15
• Study First Posted: 2009-04-16
• Study Start: 2009-05
• Status Verified: 2009-10
• Study Completion: 2009-10
• Last Update Submitted: 2009-10-28
• Last Update Posted: 2009-10-29

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 7200

Inclusion Criteria

• Provision of informed consent.
• Patients 50+ years old, with at least one additional CV risk factor (with no previous CV event or hospitalisation for a CV event) from Primary Care or hospital outpatient clinic.

Exclusion Criteria

• Subjects who are unwilling or unable to provide informed consent
• Previous CV disease event or hospitalisation for a CV event
• Current participation in a clinical trial

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
LDL-cholesterol, systolic and diastolic blood pressure, Tot. cholesterol, Non-HDL cholesterol, HDL-cholesterol, waist and hip circumference, HbA1c	Cross-sectional
Gender, age, patients with diabetes and/or hypertension (%), smoker status, family medical history.	Cross-sectional

Secondary Outcome Measures

Name	Time	Method
Biomarkers: Apo-A1, Apo-B, Hs-CRP, Creatinine, albuminuria, uric acid, glomerular filtration rate.	Cross-sectional
BMI, Score based 10 year CHD mortality > 5%, High Risk patients (no. and %)	Cross-sectional
Use of concomitant medication: anticoagulant, anti hypertensive, antidiabetic, lipid-lowering drugs	Cross-sectional

Trial Locations

Locations (1)

Research Site; 🇬🇧 Worthing, United Kingdom